Towards Healthcare
Anxiety Disorders Treatment Market Report (2024 - 2032)

Anxiety Disorders Treatment Market Size Envisioned at USD 15.90 Billion by 2032

The report covers Anxiety Disorders Treatment Market Size, Companies and Segmentations by disorder type, treatment, hospital settings, and geography. Disorder types include panic disorder, agoraphobia, generalized anxiety, social anxiety, specific phobia and others. Treatments encompass various drug classes such as SSRIs, SNRIs, TCAs, MAOIs, mixed antidepressants, GABAergic drugs, benzodiazepines, antipsychotics, beta-blockers, antihistamines and others, as well as therapy and other non-drug treatments. Hospital settings range from inpatient to outpatient facilities. The report offers the value (in USD Billion) for the above segments.

Anxiety Disorders Treatment Market Size and Future Analysis

The anxiety disorders treatment market size achieved a value of USD 11.49 billion in 2023 and is anticipated to reach USD 15.90 billion by 2032. Projections suggest a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.

Anxiety Disorders Treatment Market Size 2023 - 2032

Unlock Infinite Advantages: Subscribe to Annual Membership

Report Highlights:

  • Generalized Anxiety disorders held the largest market share of 34% in 2022.
  • SSRIs (Selective Serotonin Reuptake Inhibitors) by drug class exhibited largest 32% market share in 2022.
  • Hospital outpatient settings led the charge in 2022 with a commanding 71% market share.

There was a 12% rise in the prescription rate of the anti-anxiety drug Zoloft in March 2020. Lockdown measures, economic difficulties, and reduced social interaction have been identified as the primary factors contributing to a notable increase in depression and anxiety cases across North America.

Anxiety disorders are mental health conditions marked by excessive worry, fear, or nervousness that can mess with daily life. They come in various forms like generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobias. People with these disorders often worry too much, even when there's no real reason. They might also experience physical symptoms like sweating, trembling, or rapid heartbeat. Some may avoid situations that trigger anxiety, leading to isolation or disruption of normal activities. Panic attacks, sudden and intense episodes of fear, are common, bringing along symptoms such as chest pain or difficulty breathing. Sleep troubles are another hallmark, with insomnia or racing thoughts making it hard to rest.

CDC Data on Youth Mental Health During Covid-19

Diagnosing anxiety disorders early and providing proper treatment is vital for several reasons. Untreated anxiety can lead to other mental health issues like depression or substance abuse. effective treatment can greatly improve quality of life, helping individuals manage symptoms and lead fulfilling lives. Chronic stress and anxiety can harm physical health, contributing to problems like heart issues or weakened immunity. Fourthly, anxiety disorders can interfere with relationships and work, so timely diagnosis and treatment can help improve social functioning. Finally, early intervention can prevent anxiety disorders from becoming chronic or more severe, making them easier to treat.

Treatment usually involves a mix of therapy, medication, and lifestyle changes. Cognitive-behavioral therapy (CBT) teaches coping strategies and helps manage anxious thoughts, while medications like SSRIs or benzodiazepines may be prescribed to alleviate symptoms. Lifestyle changes such as exercise, relaxation techniques, and healthy habits can also play a role in managing anxiety.

Awareness of Mental Health

As people become more aware of mental health issues, like anxiety disorders, they're learning that it's okay to seek help. Before, there used to be a lot of stigma or shame attached to admitting you needed help with your mental health. But now, that's changing. More and more people are talking openly about their struggles, which makes others feel less alone and more comfortable seeking treatment.

  • In December 2020, the Marketing Authorization Application (MAA) for Vyepti, submitted by H. Lundbeck A/S, was accepted for assessment by the European Medicines Agency (EMA). The application sought permission to market Vyepti for the prevention of migraine in European residents. Vyepti aims to inhibit the interaction between calcitonin gene-related peptide (CGRP) and its receptor to prevent migraine attacks.
  • Between 2015 and 2020, there were approximately 76,000 grants allocated for mental health from 345 different funding organizations across 38 countries. These grants accounted for roughly 5% of all registered grants and 4% of the total research expenditure, amounting to around US$18.5 billion, dedicated to mental health initiatives. The majority of investments, around 89%, were directed to high-income nations, with the United States contributing 39% of all grants.

This shift in our culture means that people are no longer hiding their anxiety or pretending everything is okay when it's not. They're realizing that anxiety is a real condition that deserves attention, just like any other health problem. And because of this, more individuals are reaching out to professionals for support.

When people feel less judged or embarrassed about their anxiety, they're more likely to take steps to get better. This can include talking to a therapist, trying medication if needed, or exploring other treatment options. And as more people seek help, the demand for anxiety disorder treatments goes up.

It's like a ripple effect – as one person bravely shares their story, it encourages others to do the same. And the more stories we hear, the more we understand that anxiety is something many people deal with, and it's nothing to be ashamed of. So, growing mental health awareness isn't just about understanding anxiety better – it's about creating a world where everyone feels safe and supported in seeking the help they need. And as this cultural shift continues, more and more individuals will have access to the treatment and support they deserve to live happier, healthier lives.

Scientists Strive to Improve Anxiety Disorder Treatments

Researchers and scientists are always working hard to find better ways to help people with anxiety disorders. They do this by discovering and creating new treatments. One way they do this is by making new medications. These medications are like special potions that can help calm down the feelings of anxiety in the body and mind. Scientists study different chemicals in the brain to make these medications. Sometimes they also improve existing medications to make them work even better.

  • In December 2020, Big Rock Partners Acquisition Corp. and NeuroRx, a company focused on developing advanced treatments for COVID-19 and bipolar disorder, finalized a merger agreement.

But it's not just about pills. Scientists also come up with new therapy techniques. Therapy is like talking to someone who knows a lot about anxiety. Therapists help people understand why they feel anxious and teach them tricks to manage those feelings better. Sometimes they come up with new techniques that work even better than before. And then there are alternative approaches, like digital therapeutics. These are like having a personal coach right on your phone or computer. They use technology to give people tools and exercises to help them deal with anxiety wherever they are. It's like having a little helper in your pocket, reminding you that you're not alone and giving you strategies to feel better.

Global Spending on Well Being and Mental Health Apps, 2019 - 2022, USD Million

So, all these research efforts are like a big treasure hunt for better ways to treat anxiety. Each discovery brings hope to those struggling with anxiety, showing them that there are more options available to help them feel better and live happier lives. And as scientists continue to explore and innovate, the future looks brighter for everyone dealing with anxiety.

Social Anxiety Required Appropriate Treatment

The study analyzed self-reported social anxiety using the Counseling Center Assessment of Psychological Symptoms (CCAPS). Seven social anxiety items were rated on a five-point scale from 0 to 4. Social isolation, a component of the CCAPS Depression subscale, was assessed.

Social anxiety, which is feeling nervous or uncomfortable in social situations, seems to be increasing nowadays. There could be many reasons for this rise. One might be the increased use of social media and technology, which can lead to comparing ourselves to others and feeling inadequate. Also, societal pressures to fit in and be perfect can make people more anxious in social settings. Another factor could be the fast-paced and stressful nature of modern life, leaving less time for meaningful social interactions.

Treating social anxiety involves various approaches. Therapy, like cognitive-behavioral therapy (CBT), is a common treatment. In therapy, individuals learn to challenge negative thoughts and develop coping skills to manage anxiety. Medications, such as antidepressants or anti-anxiety medications, may also be prescribed to alleviate symptoms. Additionally, lifestyle changes like practicing relaxation techniques, regular exercise, and gradually facing feared social situations can be helpful. Support from friends, family, or support groups can also play a crucial role in managing social anxiety.

Changes in Self Reported Social Anxiety Symptoms and Isolation from 2010 to 2022

Understanding the factors contributing to social anxiety and seeking appropriate treatment, whether through therapy, medication, lifestyle changes, or support, can help individuals overcome their fears and improve their quality of life.

Shortage of Mental Health Professionals

In some places, there aren't enough mental health professionals, especially those who specialize in working with kids and teens. This means that if someone needs help with their mental health, they might have to wait a long time to see a therapist or psychiatrist. It's like having a really long line at the doctor's office, but for your mind instead of your body. Because there aren't enough specialists, people might not have many choices for treatment. They might have to travel far or wait months just to get an appointment. This can be really frustrating and make it harder for people to get the help they need when they need it.

One reason for this shortage is that becoming a mental health professional takes a lot of time and training. Not enough people choose this career path, so there aren't enough professionals to meet the growing demand for mental health services.

Another problem is that mental health services might not be evenly spread out. Some areas might have plenty of therapists and psychiatrists, while others have hardly any. This can make it even harder for people in those underserved areas to get help. The shortage of mental health professionals, especially in certain areas or specialties, can make it tough for people to access timely and effective treatment for their mental health concerns.

Geographical Landscape

In North America, where you live can affect how easy it is to get treatment for anxiety. Metro cities like New York, Los Angeles, and Toronto have lots of therapists and places to get help. They have special clinics, therapy centers, and even research places just for anxiety. Places near these big cities, called suburbs, also have some options for treatment, but they might not have as many choices as the big cities. People in the suburbs might need to go into the city for certain types of treatment. Because of the COVID-19 pandemic, more people are using telehealth. This means you can talk to a therapist or doctor from your home using a computer or phone. This is helpful for people who live far away from cities or don't have many options for treatment nearby. Telehealth makes it easier for everyone to get help for anxiety, no matter where they live.

In some parts of Asia, there's still a lot of shame around mental health issues. This makes it hard for people to talk about their problems or ask for help. Because of this, there aren't always enough resources for treating anxiety disorders. Many countries in Asia struggle to build good mental health services because there aren't enough trained professionals, money, or places for people to get help. Asia is a big and diverse place with lots of different cultures and languages. This affects how people see mental health and what kind of help they want. So, treatments need to understand and respect these cultural differences to help everyone who needs them.

Competitive Landscape

The anxiety disorder treatment is highly competitive, with numerous players offering a variety of products and services aimed at alleviating anxiety symptoms. Providers range from pharmaceutical companies offering medications to therapy clinics offering counseling services. Medication such as SSRIs and benzodiazepines are commonly prescribed for anxiety disorder, with each medication having its own benefits and side effects, exposure therapy, and mindfulness therapy among others. Technological advancements have also led to the development of digital therapeutics and mobile apps designed to provide support outside of the traditional therapy session.

  • In November 2020, Janssen Pharmaceutical N.V. collaborated with mental healthcare provider Koa Health to research the combination of digital cognitive behavioral therapy and pharmacological treatment for patients with treatment-resistant major depressive disorder.
  • In August 2020, the US Food and Drug Administration (FDA) approved the addition of intranasal SPRAVATO, a nasal spray, to oral antidepressant therapy for managing depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior. This announcement was made by Janssen Pharmaceuticals N.V.
  • In June 2020, Neurocrine Bioscience, Inc. and Takeda Pharmaceutical Company Limited finalized an agreement to jointly develop innovative treatments for psychiatric disorders.

Anxiety Disorders Treatment Market Companies

  • Pfizer Inc.
  • Merck KGaA
  • Sanofi
  • Bristol-Myers Squibb Company
  • Elli Lilly
  • Teva Pharmaceutical Industries
  • Bayer AG
  • Biocare Medical, LLC
  • GSK plc.
  • Mitsubishi Chemical Group Corporation

Anxiety Disorders Treatment Market Segments

By Disorder Type

  • Panic Disorder
  • Agoraphobia
  • Generalized Anxiety
  • Social Anxiety
  • Specific Phobia
  • Others

By Treatment

  • Drug Class
    • SSRIs
    • SNRIs
    • TCAs
    • MAOIs
    • Mixed antidepressants
    • GABAergic Drugs
    • Benzodiazepines
    • Antipsychotics
    • Beta-blockers
    • Antihistamines
    • Other Drug Classes
  • Therapy
  • Other Treatments

By Hospital Settings

  • Inpatient
  • Outpatient

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.


Anxiety is a psychological condition characterized by feelings of worry, nervousness, or unease, often about uncertain outcomes or future events. It can manifest as physical symptoms such as increased heart rate, sweating, and trembling.

The driving factors of the anxiety disorders treatment market include increased awareness about mental health, growing acceptance of therapy and medication for anxiety, and advancements in treatment options such as psychotherapy, medication, and digital therapeutics.

North America leads the market for anxiety disorder treatment.

World Health organization, Food and Drug Administration, Centers for Disease Control and Prevention, ScienceDirect,